The Chicago Entrepreneur

FDA approves Pfizer’s first gene therapy for rare inherited bleeding disorder

The agency greenlit the drug, which will be marketed as Beqvez, for adults with moderate to severe hemophilia B. 

Previous post Exxon stock falls as earnings miss on lower natural gas prices and squeezed refining margins
Next post Exxon Mobil’s stock falls after profit drops below expectations, as refining margins and natural gas prices dropped